Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: AS A RESULT OF REEXAMINATION, IT HAS BEEN DETERMINED THAT zeus
6
Dec 15, 2009 09:17AM

The market had it pegged. The original NIRC that moved the share price was, pretty much, official enough for most watching this stock. As I mentioned yesterday.....no volume indicated that either it was not going to be in the Gazette or it would be viewed as a redundant event. Too much other crap going on, as well. Man, this is making me old. good luck

Share
New Message
Please login to post a reply